Who is locus biosciences? Locus Biosciences, Inc. operates as a biotechnology company. The Company focuses on the discovery and development of a next generation platform for programmed cell death. Locus Biosciences serves customers in the State of North Carolina.What is ledlocus biosciences? Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina which to develop phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Case9, delivered by engineered bacteriophages.How many employees does locus have in 2020? In November 2020, Locus had 52 people and planned to expand to 85 by 2021. CRISPR-Cas3 is more destructive than the better known CRISPR–Cas9 used by companies like Caribou Biosciences, Editas Medicine, Synthego, Intellia Therapeutics, CRISPR Therapeutics and Beam Therapeutics.Who is rodolphe locus? Rodolphe was at the genesis point of CRISPR with Caribou Biosciences and Intellia Therapeutics and brought that set of skills to launch the NCSU founded business Locus Biosciences. He is editor-in-chief of the CRISPR Journal and frequent contributor to media and educational efforts.
Locus Biosciences is a biotechnology company that develops CRISPR-engineered precision antibacterial products. Starting in Infectious Disease, Locus is strategically pursuing additional, more complex therapeutic areas as we continue to expand our precision therapeutics platform Contact Us. Name. First Last. Email.